Orientin T6S0721
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
1. Orientin may be regarded as a candidate therapeutic agent for treatment of vascular inflammatory diseases via inhibition of the HMGB1 signaling pathway. 2. Orientin protects vascular barrier integrity by inhibiting hyperpermeability, expression of CAMs
CAS nr:
28608-75-5
Purity:
98%
Molecular Weight:
448,38
SMILES:
OC[C@H]1OC([C@H](O)[C@@H](O)[C@@H]1O)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccc(O)c(O)c1
Formula:
C21H20O11
Pathway:
Others
Target:
Others
